{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:23:25Z","timestamp":1747167805368,"version":"3.40.5"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.msard.2023.105099","type":"journal-article","created":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T13:51:50Z","timestamp":1697982710000},"page":"105099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cerebrospinal fluid cell counts in autoimmune encephalitis: Technological limitations and transparent reporting of laboratory data"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4614-681X","authenticated-orcid":false,"given":"John L","family":"Frater","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2023.105099_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577508","article-title":"Prognostic value of acute cerebrospinal fluid abnormalities in antibody-positive autoimmune encephalitis","volume":"353","author":"Broadley","year":"2021","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.msard.2023.105099_bib0002","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1164\/rccm.201603-0507OC","article-title":"Anti-N-methyl-d-aspartate receptor encephalitis in adult patients requiring intensive care","volume":"195","author":"de Montmollin","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.msard.2023.105099_bib0003","doi-asserted-by":"crossref","DOI":"10.1080\/14767058.2023.2194480","article-title":"Cerebrospinal fluid white blood cell counts: technical observations","volume":"36","author":"Frater","year":"2023","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.msard.2023.105099_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104996","article-title":"Cerebrospinal fluid indices as predictors of treatment response in autoimmune encephalitis","volume":"79","author":"Popova","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.msard.2023.105099_bib0005","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ajcp\/aqx026","article-title":"A new automated technology for cerebrospinal fluid cell counts: comparison of accuracy and clinical impact of GloCyte, Sysmex XN, and Manual Methods","volume":"147","author":"Sandhaus","year":"2017","journal-title":"Am. J. Clin. Pathol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823006004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823006004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T01:22:17Z","timestamp":1724894537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823006004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":5,"alternative-id":["S2211034823006004"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.105099","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid cell counts in autoimmune encephalitis: Technological limitations and transparent reporting of laboratory data","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.105099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105099"}}